James M. Brooks, SVP of Business Development at OptimizeRx Corp (OPRX), bought 10,000 shares at $1.06 ($11K) on 2016-06-08, disclosed to the SEC on 2016-06-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.